Akrevia Therapeutics' Series A Round

Akrevia Therapeutics raised a round of funding on September 27, 2018.

Akrevia Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's Aklusion platform technology allows biologi…

Articles about Akrevia Therapeutics' Series A Round: